Discontinued — last reported Q4 '25

Net Income

Income from Discontinued Ops

Over 4 years (FY 2021 to FY 2025), Income from Discontinued Ops shows an upward trend with a -51.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementIncome Statement
SectionNet Income
CategoryOther
SignalHigher is better
VolatilityVolatile
First reportedQ1 2022
Last reportedQ4 2025

How to read this metric

Usually non-recurring; large losses may indicate costs associated with restructuring or divestiture programs.

Detailed definition

Captures the net financial impact of business segments that have been sold, shut down, or are held for sale. This allows...

Peer comparison

Highly specific to companies undergoing restructuring or portfolio optimization.

Metric ID: discontinued_operations

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$24.00M-$9.00M-$458.00M-$9.00M$34.00M-$21.00M$2.00M$1.00M-$2.00M$12.00M-$26.00M-$5.00M$17.00M-$8.00M$7.00M$0.00$25.00M$0.00$0.00-$13.00M
QoQ Change-137.5%<-999%+98.0%+477.8%-161.8%+109.5%-50.0%-300.0%+700.0%-316.7%+80.8%+440.0%-147.1%+187.5%-100.0%-100.0%
YoY Change+41.7%-133.3%+100.4%+111.1%-105.9%+157.1%<-999%-600.0%+950.0%-166.7%+126.9%+100.0%+47.1%+100.0%-100.0%
Range-$458.00M$34.00M
CAGR-12.1%
Avg YoY Growth-51.4%
Median YoY Growth+47.1%

Frequently Asked Questions

What is Pfizer's income from discontinued ops?
Pfizer (PFE) reported income from discontinued ops of -$13.00M in Q1 2026.
What is the long-term trend for Pfizer's income from discontinued ops?
Over 4 years (2021 to 2025), Pfizer's income from discontinued ops has grown at a -51.0% compound annual growth rate (CAGR), from -$434.00M to $25.00M.
What does income from discontinued ops mean?
Profit or loss from business units that are no longer part of the core operations.